Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trismus in patients with head and neck cancer and 5-year overall survival.
Astradsson T, Laurell G, Ahlberg A, Nikolaidis P, Johansson H, Ehrsson YT. Astradsson T, et al. Among authors: johansson h. Acta Otolaryngol. 2018 Dec;138(12):1123-1127. doi: 10.1080/00016489.2018.1511059. Epub 2019 Jan 27. Acta Otolaryngol. 2018. PMID: 30686104
Mandibular resection in patients with head and neck cancer: acute and long-term complications after reconstruction.
Sjöström M, Danielsson D, Munck-Wikland E, Nyberg J, Sandström K, Thor A, Johansson H, Ceghafi P, Dybeck Udd S, Emanuelsson J, Forsberg Pettersson L, Halle M, Laurell G. Sjöström M, et al. Among authors: johansson h. Acta Otolaryngol. 2022 Jan;142(1):78-83. doi: 10.1080/00016489.2021.2021283. Epub 2022 Jan 13. Acta Otolaryngol. 2022. PMID: 35023428
Early self-care rehabilitation of head and neck cancer patients.
Ahlberg A, Engström T, Nikolaidis P, Gunnarsson K, Johansson H, Sharp L, Laurell G. Ahlberg A, et al. Among authors: johansson h. Acta Otolaryngol. 2011 May;131(5):552-61. doi: 10.3109/00016489.2010.532157. Acta Otolaryngol. 2011. PMID: 21492066 Free PMC article. Clinical Trial.
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial.
Matikas A, Johansson H, Grybäck P, Bjöhle J, Acs B, Boyaci C, Lekberg T, Fredholm H, Elinder E, Margolin S, Isaksson-Friman E, Bosch A, Lindman H, Adra J, Andersson A, Agartz S, Hellström M, Zerdes I, Hartman J, Bergh J, Hatschek T, Foukakis T. Matikas A, et al. Among authors: johansson h. Clin Cancer Res. 2023 Feb 1;29(3):532-540. doi: 10.1158/1078-0432.CCR-22-2829. Clin Cancer Res. 2023. PMID: 36449695 Clinical Trial.
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial.
Hatschek T, Foukakis T, Bjöhle J, Lekberg T, Fredholm H, Elinder E, Bosch A, Pekar G, Lindman H, Schiza A, Einbeigi Z, Adra J, Andersson A, Carlsson L, Dreifaldt AC, Isaksson-Friman E, Agartz S, Azavedo E, Grybäck P, Hellström M, Johansson H, Maes C, Zerdes I, Hartman J, Brandberg Y, Bergh J. Hatschek T, et al. Among authors: johansson h. JAMA Oncol. 2021 Sep 1;7(9):1360-1367. doi: 10.1001/jamaoncol.2021.1932. JAMA Oncol. 2021. PMID: 34165503 Free PMC article. Clinical Trial.
1,436 results